<--- Back to Details
First PageDocument Content
Francis M. Mullen / Diversion Investigator / DEA / United States federal executive departments / Bureau of Narcotics and Dangerous Drugs / Illegal drug trade / Clandestine chemistry / Law / Thomas J. Harrigan / FBI agents / Drug Enforcement Administration / United States Department of Justice
Date: 2010-06-26 20:45:09
Francis M. Mullen
Diversion Investigator
DEA
United States federal executive departments
Bureau of Narcotics and Dangerous Drugs
Illegal drug trade
Clandestine chemistry
Law
Thomas J. Harrigan
FBI agents
Drug Enforcement Administration
United States Department of Justice

Add to Reading List

Source URL: www.deaeducationalfoundation.org

Download Document from Source Website

File Size: 1,27 MB

Share Document on Facebook

Similar Documents

Drugs in the United States / Health / Pharmaceutical sciences / Drug Enforcement Administration / National Association of Boards of Pharmacy / Pharmacist / Bureau of Narcotics and Dangerous Drugs / Pharmacy / Federal Bureau of Narcotics

MISSOURI PHARMACY DIVERSION CONFERENCE 2016 WHEN:

DocID: 1rcnw - View Document

Neurochemistry / Methamphetamine / Clinical medicine / Neuropsychology / Decongestants / Norepinephrine releasing agents / Illegal drug trade / Clandestine chemistry / Pseudoephedrine / Oklahoma Bureau of Narcotics and Dangerous Drugs Control / Stimulant / Ephedrine

Methamphetamine: The Resurgence of Manufacturing After Oklahoma House Bill 2176 Rashi K. Shukla E. Elaine Bartgis University of Central Oklahoma

DocID: 1qrcP - View Document

Drugs in the United States / Drug Enforcement Administration / Pharmacist / National Association of Boards of Pharmacy / Bureau of Narcotics and Dangerous Drugs / Federal Bureau of Narcotics / Pharmacy / Drug diversion

MISSOURI PHARMACY DIVERSION CONFERENCE 2016 WHEN:

DocID: 1or7O - View Document

Drugs in the United States / Drug Enforcement Administration / Euphoriants / Morphinans / Hydrocodone / Ketones / Bureau of Narcotics and Dangerous Drugs / Federal Bureau of Narcotics / Narcotic

Steps to Take to Add Schedule II (Medications Containing Hydrocodone only) to Your Controlled Substance Prescriptive Authority Effective August 28, 2015, sectionRSMo grants permission for APRNs who have been d

DocID: 1mdh4 - View Document

Drug Enforcement Administration / Bureau of Narcotics and Dangerous Drugs / Medical prescription / Federal Bureau of Narcotics / Nursing / Controlled Substances Act / Mid-level practitioner / Health / Medicine / Government

Microsoft Word - Memo for publishing on new BNDD rules[removed]docx

DocID: RoEV - View Document